ArticleClinical pharmacology and therapeutics2026

Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting.

Danijela Stojanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.